Skip to main content

More than 25 members and affiliated physicians of the UNC Lineberger Comprehensive Cancer Center will present their work to the attendees at the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, being held May 30 through June 3. The annual meeting brings together more than 25,000 oncology professionals to present research and discuss new treatment options.

The following UNC Lineberger members will be presenting or moderating workshops and seminars at the conference:

Pre-ASCO Conference (May 29-30)

All DayStephan Moll (Speaker and Program Co-Chair) – Hematology for the Oncologist – “Thrombophilia: Screening, Testing, and Treatment” />

Friday, May 30

1 p.m.Thomas Stinchcombe (chair) – “Maintenance of Certification and Lifelong Learning Workshop”

2:45 p.m.Joel Tepper (Speaker) – “Radiation oncology advances”

4 p.m. – Frances Collichio (chair) – “Special Session for Program Directors and Key Clinical Faculty: Intragenerational Learning- Teaching Millennial Learners and Practical Use of Milestones”

Saturday, May 31

8 a.m. – Matthew Ewend – “Breast Cancer Central Nervous System Metastases: A Strategic Approach to Integrating Local and Systemic Therapies”

8 a.m. – Hyman Muss (Speaker) – “Developing a Geriatric Oncology Presence at Your Academic Institution or Community-Based Practice”

8 a.m. – Stergios Moschos (Poster Presenter) – Melanoma/Skin Cancers – “Prognostic significance of PD-L1 expression, angiogenesis, and hypoxia in melanoma brain metastases (MBM): A histopathologic analysis.”

8 a.m. Victoria Lin Bae-Jump (Poster Presenter) – “Endometrial cancer survivors: What is their knowledge about obesity?”

8 a.m. – Andrew Wang (Poster Presenter) – “A phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer

8 a.m. – Michael Eblan (Poster Presenter) – Gynecologic Cancer – “Population-based analysis of mortality over time in endometrial cancer

1:15 p.m. – Myla Lai-Goldman (Poster Presenter) – “Evaluation of a lung cancer RNA expression subtyping panel and comparison with histologic diagnosis in lung tumor samples from multiple data sets including The Cancer Genome Atlas (TCGA)”

5 p.m. – Lisa Carey (Speaker) – “Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa)”

Sunday, June 1

7:30 a.m. – Francis Collichio (Chair) – Training Program Directors’ Breakfast

8 a.m. – Emily Guerard (Poster Presenter) – Patient and Survivor Care – “Evaluation of falls in older adults in a comprehensive cancer center: how are we doing?”

8 a.m. – Juneko Grilley-Olson (Poster Presenter) – Developmental Therapeutics – Clinical Pharmacology and Experimental Therapeutics – “Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients”

8 a.m. – Hyman Muss (Poster Presenter) – Patient and Survivor Care – “The underutilization of occupational and physical therapy for older adults with cancer”

8 a.m. Hyman Muss (Poster Presenter) – “Evaluation of falls in older adults in a comprehensive cancer center: How are we doing?”

Monday, June 2

1 p.m. – Matthew Milowsky (Chair) and William Kim (Speaker) – “From Genetics to Geriatric Medicine in Bladder Cancer”

1:15 p.m. – William Kim (Speaker) – From Genetics to Geriatric Medicine in Bladder Cancer

1:15 p.m. – Katie Reeder-Hayes (Poster Presenter) – Health Services Research – “Cost-effectiveness of alternative adjuvant bisphosphonate regimens in postmenopausal women with early breast cancer”

1:15 p.m. – Stephanie Wheeler (Poster Presenter) – “Cost-effectiveness of alternative adjuvant bisphosphonate regimens in postmenopausal women with early breast cancer”

3 p.m. – Lisa Carey (Speaker) – A Brave New World: Contemporary Management of HER2-Positive Breast Cancer – “First Things First: New Choices and Paradigms in Preoperative Therapy for HER2 Positive Breast Cancer”

Tuesday, June 3

8 a.m. – Ethan Basch (Chair) – “Incorporating the Patient’s Voice: Patient Engagement in Research”

8 a.m. – Nathan Sheets (Poster Presenter) – “Population-based analysis of treatment receipt in prostate cancer patients who initially pursued active surveillance (AS)”

8 a.m. – Ronald Chen (Poster Discussion) – Poster Highlights Session – “Adoption of hypofractionated radiotherapy for early-stage invasive breast cancer after publication of randomized trials”

9:45 a.m. – Thomas Stinchcombe (Speaker) – “Why is Chemotherapy Here to Stay in Lung Cancer?’

9:45 a.m. – Aaron Falchook (Oral Presentation) – Oral Abstract Session: Breast Cancer – Triple-Negative/Cytotoxics/Local Therapy – “Adoption of hypofractionated radiotherapy (HyRT) for ductal carcinoma in situ (DCIS): A SEER-Medicare study.”

Published by ASCO but not presented at meeting

Kirsten Nyrop – “Joint pain and physical activity among breast cancer survivors on aromatase inhibitor therapy”

Thomas Stinchcombe – “Preliminary results of a phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology (NSCLC-NS) with disease progression after a bevacizumab (bev) containing therapy”

Victoria Lin Bae-Jum – “Endometrial cancer outcomes in hypertensive women treated with beta-blocker”

Anne-Marie Meyer – “Geographic variation in high-risk uterine cancer histology and access to care”

Til Sturmer – “Initial therapy with transarterial chemoembolization (TACE) versus Yttrium90 radioembolization (Y90) for hepatocellular carcinoma (HCC)”

Hyman Muss and Nisha Mehta – “Is computerized tomography (CT) sufficient without bone scan (BS) for routine, asymptomatic breast cancer (BC) staging?”

For more information about the meeting, visit the ASCO conference website. Video updates for the conference will be available on ASCO’s Youtube page